Minecraft Gamers Can Now Earn Trilium From the Alien Worlds Metaverse
Minecraft, the best-selling video game in history engaging more than 170 million players, will be able to earn Trilium, the native cryptocurrency in the Alien Worlds metaverse. Alien Worlds is one of the largest play to earn (P2E) blockchain games and NFT metaverse.
Launched in 2020, Alien Worlds has grown to be the second largest blockchain platform by monthly active users. In the game, users can play with unique digital items (NFTs), stake Trilium tokens, travel on Alien Worlds Missions to other planets, vote in elections, and run for planetary council. The game’s 6 planet DAOs compete with each other for Trilium, encouraging user collaboration.
The new interoperability bridge to the world’s longest running and most popular online building platform will have resounding effects in the traditional and blockchain gaming worlds. The bridge will accelerate the onboarding of non-blockchain gamers onto the Alien Worlds metaverse, and also due to the open sourced nature of the code developed - empower other Minecraft servers to earn play-to-earn rewards. Plus, it will allow other blockchain projects to tap into Minecraft's vast user base.
Additionally, this interoperability will offer traditional gamers the opportunity to earn assets, in this case Trilium, and soon NFTs, for completing quests. Players are able to exchange their digital assets freely, enabling them to earn real world utility by getting involved in Alien Worlds’ simulated economy.
“This bridge is significant in that we are linking one of the world’s most popular decentralized games to the blockchain, and opening up a world of new possibilities for Minecraft players through our social metaverse,” says Alien Worlds co-founder Saro McKenna. “We think our combination of economics, team strategy and earning will convert Minecraft players of all ages into Web3 players.”
Additionally, earning Trilium will allow Minecraft gamers to stake the fungible token to one of the Alien Worlds Planet DAOs, which hold some of the largest treasuries in the space. Staked Trilium translates into voting power to determine control of planetary treasuries. Minecraft players will not only be able to learn about DAOs, but also to participate in the collaborative, competitive and highly strategic environment that their gamification entails.
About Alien Worlds
Alien Worlds is a breakthrough NFT Metaverse and one of the world’s most popular play-to-earn blockchain games, where users can play with unique digital assets (NFTs), stake Trilium tokens, travel on Missions to the planets, vote in elections, and run for planetary council. The game’s 6 planet DAOs compete with each other for Trilium, allowing users to collaborate, compete and strategize with one another.
With almost 7 million all-time players and more than 700,000 Monthly Active Users (number of unique wallet addresses interacting with Alien Worlds' smart contracts on a monthly basis, DappRadar), Alien Worlds has rapidly climbed the DappRadar ranking charts and inspired individuals to scale new heights of imagination in order to create, share and thrive in the Social Metaverse.
To access and play Alien Worlds and the new Alien Worlds Missions game, visit www.alienworlds.io, play.alienworlds.io/missions and the Explorers Station.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220328005182/en/
Contact information
Tonie Wells - tonie.wells@wachsman.com
+ 1 313 284-6270
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release
Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i
Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release
Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct
Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release
Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we
Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release
AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by
illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release
illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom